Farmaceutica Remedia (BSE:RMAH) Interest Expense : lei-0.1 Mil (TTM As of Dec. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Farmaceutica Remedia Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Farmaceutica Remedia's interest expense for the three months ended in Dec. 2023 was lei -0.1 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was lei-0.1 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Farmaceutica Remedia's Operating Income for the three months ended in Dec. 2023 was lei 2.0 Mil. Farmaceutica Remedia's Interest Expense for the three months ended in Dec. 2023 was lei -0.1 Mil. Farmaceutica Remedia's Interest Coverage for the quarter that ended in Dec. 2023 was 23.83. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Farmaceutica Remedia Interest Expense Historical Data

The historical data trend for Farmaceutica Remedia's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Farmaceutica Remedia Interest Expense Chart

Farmaceutica Remedia Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-0.64

-0.17

-0.11

-0.16

-0.12

Farmaceutica Remedia Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Interest Expense	Get a 7-Day Free Trial															-0.02	-0.02	-0.01	-0.02	-0.08

Farmaceutica Remedia Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was lei-0.1 Mil.

Farmaceutica Remedia (BSE:RMAH) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Farmaceutica Remedia's Interest Expense for the three months ended in Dec. 2023 was lei-0.1 Mil. Its Operating Income for the three months ended in Dec. 2023 was lei2.0 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2023 was lei1.2 Mil.

Farmaceutica Remedia's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2023 )	/	Interest Expense (Q: Dec. 2023 )
	=	-1	*	1.978	/	-0.083
	=	23.83

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Farmaceutica Remedia SA has enough cash to cover all of its debt. Its financial situation is stable.

Farmaceutica Remedia (BSE:RMAH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Farmaceutica Remedia SA (BSE:RMAH) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 2 Nicolae Balcescu Boulevard, Hunedoara County, Deva, ROU, 330040

Website

https://corporate.remedia.ro

Farmaceutica Remedia SA is engaged in drug sales activities, marketing, and health products. It provides marketing and promotion services for medicines. The company offers services offered, including logistics services, medical marketing, and promotion, and pharmaceutical registrations, but also professionalism and performance differentiate the company from other competitors and position it as a partner for launching, promoting, and distributing pharmaceutical products in Romania and other countries in Eastern Europe.

Farmaceutica Remedia (BSE:RMAH) Headlines

No Headlines